Related Experiment Video
Updated: Feb 13, 2026

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
Published on: April 11, 2018
Developments in the management of advanced soft-tissue sarcoma - olaratumab in context
Gianluca Moroncini1, Elena Maccaroni2, Ilaria Fiordoliva2
1Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Ancona, Italy.
Lartruvo (olaratumab) is a novel antibody treatment for advanced soft-tissue sarcomas, showing improved overall survival when combined with doxorubicin. This first-in-class therapy offers a significant survival benefit for patients with this rare cancer.
Area of Science:
- Oncology
- Immunotherapy
- Pharmacology
Background:
- Lartruvo (olaratumab) is a fully human IgG1 monoclonal antibody targeting platelet-derived growth factor receptor alpha (PDGFRα).
- Olaratumab has demonstrated in vitro and in vivo antitumor activity in various cancer cell lines.
- It is the first-in-class antibody approved for advanced soft-tissue sarcomas (STSs) in combination with doxorubicin.
Purpose of the Study:
- To evaluate the rationale for using olaratumab in advanced STSs.
- To assess the emerging role of olaratumab in clinical practice.
- To review the clinical trial data supporting olaratumab's efficacy.
Main Methods:
- Phase Ib/II trial evaluating olaratumab plus doxorubicin versus doxorubicin monotherapy.
- Analysis of progression-free survival (PFS) as the primary endpoint.
- Final analysis of overall survival (OS) as a key secondary endpoint.
Main Results:
- Median PFS was improved with olaratumab plus doxorubicin (6.6 months) compared to doxorubicin alone (4.1 months).
- Median OS showed a significant increase with olaratumab plus doxorubicin (26.5 months) versus doxorubicin alone (14.7 months).
- Regulatory approvals were granted by the FDA and EMA based on these promising results.
Conclusions:
- Olaratumab in combination with doxorubicin demonstrated a significant overall survival benefit in advanced STSs.
- The drug received accelerated approval from regulatory bodies, highlighting its potential clinical impact.
- A confirmatory Phase III trial (ANNOUNCE) is ongoing to validate these findings.
Related Concept Videos
Vygotsky's Cognitive Development in Cultural Context
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques
Self Within Cultural Contexts
Impact of Social Context on Individuals
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Overview of Advanced Functional Groups
Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.

